J&J Philippines Leads The Fight Against Prostate Cancer Through Better Awareness And Education
Working towards “a future where the disease is a thing of the past” – to take a step towards this goal, Johnson & Johnson (J&J) Philippines, will again be supporting the initiatives of the Philippine Urological Association (PUA). For 2022 , PUA is ramping up education on one specific type of cancer that both patients and healthcare personnel still lack ample awareness of prostate cancer, one of the top five cancers affecting Filipino males across the country (WHO Globocan Report 2020 - Philippines, March 2021 ). “A lot of prostate cancer cases are detected late because of this lack of education and awareness, but prostate cancer can be ‘curable’ if diagnosed early enough,” says Dr. Erwin Benedicto, J&J Southeast Asia portfolio medical director. “There are also new therapies now available, even to advanced prostate cancer patients, that do not require chemotherapy.” Evidence of this can be seen in the comparison of prostate cancer mortality rates between developed...